Cardiac troponin T vs other biochemical markers in patients with congestive heart failure

Yukiko Nishio1, Yukihito Sato, Ryoji Taniguchi

  • 1Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Insights

Elevated cardiac troponin T (cTnT) indicates ongoing myocardial injury and is linked to worse outcomes in congestive heart failure (CHF). High cTnT levels correlate with markers of cardiac fibrosis, inflammation, and metabolic issues, predicting higher rehospitalization rates.

Area of Science:

  • Cardiology
  • Biochemistry
  • Internal Medicine

Background:

  • Myocardial injury can lead to cardiac remodeling and congestive heart failure (CHF).
  • Cardiac troponin T (cTnT) is a sensitive marker of myocardial injury and a predictor of long-term outcomes in CHF patients.

Purpose of the Study:

  • To investigate the relationship between serum cTnT levels and other biochemical markers in patients with CHF.
  • To identify predictors of death or rehospitalization for CHF.

Main Methods:

  • 145 hospitalized CHF patients were divided into low (<0.01 ng/ml) and high (>=0.01 ng/ml) serum cTnT groups.
  • Correlations between cTnT and markers like BNP, ICTP, PIIIP, renin, NOREPI, CRP, cholesterol, Hb, uric acid, and HbA1c were examined.
  • Predictive values for death or rehospitalization were assessed using univariate and multivariate analyses.

Main Results:

  • Patients with high cTnT showed elevated BNP, ICTP, PIIIP, NOREPI, CRP, uric acid, and HbA1c.
  • Conversely, high cTnT patients had lower cholesterol and hemoglobin levels.
  • High cTnT was associated with a significantly higher rate of death or rehospitalization for CHF (41% vs 9%).

Conclusions:

  • Ongoing myocardial injury, indicated by high cTnT, is associated with sympathetic system activation, cardiac fibrosis, inflammation, and metabolic abnormalities in CHF patients.
  • High cTnT and elevated renin levels were identified as significant independent predictors of adverse outcomes in CHF.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...